SSA
ZYME icon

Schonfeld Strategic Advisors’s Zymeworks ZYME Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-288,571
Closed -$7.6M – 2755
2025
Q4 		$7.6M Buy
288,571
+180,783
+168% +$3.94M 0.03% 426
2025
Q3 		$1.84M Buy
+107,788
New +$1.54M 0.01% 1078
2025
Q2 		– Sell
-21,900
Closed -$261K – 2622
2025
Q1 		$261K Sell
21,900
-900
-4% -$12.3K ﹤0.01% 1849
2024
Q4 		$334K Buy
+22,800
New +$319K ﹤0.01% 1570
2022
Q2 		– Sell
-75,200
Closed -$493K – 3076
2022
Q1 		$493K Buy
+75,200
New +$670K ﹤0.01% 1382
2021
Q2 		– Sell
-16,817
Closed -$531K – 2371
2021
Q1 		$531K Buy
+16,817
New +$683K 0.01% 1117
2020
Q4 		– Sell
-23,353
Closed -$1.09M – 1931
2020
Q3 		$1.09M Buy
23,353
+17,163
+277% +$589K 0.02% 680
2020
Q2 		$223K Buy
+6,190
New +$228K 0.01% 1074
2019
Q3 		– Sell
-79,200
Closed -$1.74M – 1283
2019
Q2 		$1.74M Buy
+79,200
New +$1.45M 0.06% 318

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schonfeld Strategic Advisors's ZYME Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 288,571 shares — an estimated $7.6M sold.

Schonfeld Strategic Advisors first reported a position in ZYME in Q2 2019 and held it in 9 quarters. The position peaked at $7.6M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 288,571 Zymeworks shares in Q1 2026, an estimated $7.6M.
  • Schonfeld Strategic Advisors first reported a position in Zymeworks in Q2 2019 and held it in 9 quarters.
  • Schonfeld Strategic Advisors's Zymeworks position peaked at $7.6M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.